Ribosomal Protein L36a Inhibitors
The chemical class known as Ribosomal Protein L36a Inhibitors refers to a group of compounds that specifically target and interact with the ribosomal protein L36a. Ribosomal proteins are integral components of the ribosome, the cellular machinery responsible for protein synthesis. Among these, L36a holds a crucial role in maintaining the structural integrity and functionality of the ribosome during the translation process. Inhibitors within this chemical class are characterized by their ability to bind to the ribosomal protein L36a, modulating its activity and disrupting the overall ribosomal function.
By affecting the function of L36a, these inhibitors could indirectly impact protein synthesis within the cell. The development and study of Ribosomal Protein L36a Inhibitors contribute to a deeper understanding of ribosome biology and its intricate regulatory mechanisms. This knowledge could unveil insights into cellular processes and may have implications in various fields of research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine is a natural alkaloid compound that has been investigated for its potential to inhibit protein synthesis by interacting with the ribosome, including ribosomal protein L36a. | ||||||
Sinefungin | 58944-73-3 | sc-203263 sc-203263B sc-203263C sc-203263A | 1 mg 100 mg 1 g 10 mg | $271.00 $5202.00 $40368.00 $704.00 | 4 | |
Sinefungin is a nucleoside analog that has shown inhibitory effects on ribosomal protein L36a, among other ribosomal proteins. It has been studied for its potential antimicrobial and antitumor activities. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is an antibiotic that inhibits protein synthesis by binding to the large ribosomal subunit, potentially affecting ribosomal protein L36a. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin is a well-known chemotherapeutic agent that can target ribosomal proteins, potentially including L36a, to inhibit protein synthesis in cancer cells. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin is a naturally occurring antibiotic that resembles the 3' end of an aminoacyl-tRNA. It can interact with the ribosome and inhibit protein synthesis, possibly involving ribosomal protein L36a. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide is a commonly used inhibitor of protein synthesis that binds to the ribosome's large subunit and may affect ribosomal protein L36a. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
This compound has been investigated for its inhibitory effects on protein synthesis and its potential use in various cancers. It may interact with ribosomal protein L36a. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
While primarily an antifungal agent, ketoconazole has been studied for its potential to inhibit protein synthesis, including potential interactions with ribosomal protein L36a. | ||||||